Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000181392 | SCV000233694 | likely pathogenic | not provided | 2016-08-10 | criteria provided, single submitter | clinical testing | Although the c.3049_3050dupTT likely pathogenic variant in the DSP gene has not been reported to our knowledge, this variant causes a shift in reading frame starting at codon Leucine 1017, changing it to a Phenylalanine, and creating a premature stop codon at position 2 of the new reading frame, denoted p.Leu1017PhefsX2. This variant is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Other downstream frameshift variants in the DSP gene have been reported in HGMD in association with cardiomyopathy (Stenson et al., 2014). Furthermore, c.3049_3050dupTTwas not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. In summary, c.3049_3050dupTT in the DSP gene is expected to be pathogenic, as loss of function variants in this gene are strongly associated with this phenotype. |